Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allium Sativum Oil vs Formocresol for Non-vital Pulpotomy
NCT05801367Phase 2Completed
- Sponsor
- University of Health Sciences Lahore
- Start
- Oct 2022
- Primary completion
- Feb 2023
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of allium sativum oil in pulp necrosis, sponsored by University of Health Sciences Lahore. Started Oct 2022; status: completed.
02
Drugs
allium sativum oil
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT05801367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05801367.